A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine

Gregers Jungersen (Inventor), Aneesh Thakur (Inventor), Claus Aagaard (Inventor), Peter Andersen (Inventor), Heidi Mikkelsen Melvang (Inventor)

    Research output: Patent

    Abstract

    The present invention provides one or more immunogenic polypeptides for use in a preventive or therapeutic vaccine against latent or active infection in a human or animal caused by a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Furthermore a single or multi-phase vaccine comprising the one or more immunogenic polypeptides is provided for administration for the prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis. Additionally, nucleic acid vaccines, capable of in vivo expression of the multi-phase vaccine comprising the one or more immunogenic polypeptides, is provided for prevention or treatment of infection with a Mycobacterium species, e.g. Mycobacterium avium subsp. paratuberculosis.
    Original languageEnglish
    IPCA61K39/04
    Patent numberWO2014114812
    Filing date31/07/2014
    CountryInternational Bureau of the World Intellectual Property Organization (WIPO)
    Priority date28/01/2013
    Priority numberEP20130152908
    Publication statusPublished - 2014

    Cite this

    Jungersen, G., Thakur, A., Aagaard, C., Andersen, P., & Melvang, H. M. (2014). IPC No. A61K39/04. A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine. (Patent No. WO2014114812).